# Novo Nordisk a S: Form 6-K, filed Apr 20, 2026

- Company: [Novo Nordisk a S](/companies/nvo.md) (CIK 353278)
- Form: 6-K
- Filed: 2026-04-20
- Accepted by EDGAR: Apr 20, 2026, 06:50 ET
- Period: 2026-04-20
- Accession: 0001171843-26-002549
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/353278/000117184326002549/f6k_042026.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/353278/000117184326002549/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/353278/000117184326002549/f6k_042026.htm

Filed Apr 20, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-002549. Last ingested by Listed: Nov 9, 2026, 17:51 ET. No prices; not investment advice.
